Potential cost-effectiveness of individualized medicine in prodromal Alzheimer’s disease by demographic, clinical and cerebrospinal fluid proteomics factors
View ORCID ProfileRon Handels, Kirsten Wesenhagen, View ORCID ProfileBetty Tijms, Charlotte Teunissen, Pieter Jelle Visser, Linus Jönsson
doi: https://doi.org/10.1101/2023.01.24.23284478
Ron Handels
1Alzheimer Centre Limburg, Maastricht University Medical Centre+; Faculty of Health, Medicine and Life Sciences; School for Mental Health and Neuroscience, Department of Psychiatry and Neuropsychology, 6200 MD, Maastricht, The Netherlands
2Div of neurogeriatrics, Dept for Neurobiology, Care Sciences and Society, Karolinska Institutet, 171 64 Solna, Sweden
Kirsten Wesenhagen
3Alzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC - Location VUmc, The Netherlands
Betty Tijms
3Alzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC - Location VUmc, The Netherlands
Charlotte Teunissen
4Neurochemistry laboratory, Department of Clinical Chemistry, Amsterdam UMC - location VUmc, Amsterdam Neuroscience, The Netherlands
Pieter Jelle Visser
3Alzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC - Location VUmc, The Netherlands
Linus Jönsson
2Div of neurogeriatrics, Dept for Neurobiology, Care Sciences and Society, Karolinska Institutet, 171 64 Solna, Sweden
Article usage
Posted January 28, 2023.
Potential cost-effectiveness of individualized medicine in prodromal Alzheimer’s disease by demographic, clinical and cerebrospinal fluid proteomics factors
Ron Handels, Kirsten Wesenhagen, Betty Tijms, Charlotte Teunissen, Pieter Jelle Visser, Linus Jönsson
medRxiv 2023.01.24.23284478; doi: https://doi.org/10.1101/2023.01.24.23284478
Potential cost-effectiveness of individualized medicine in prodromal Alzheimer’s disease by demographic, clinical and cerebrospinal fluid proteomics factors
Ron Handels, Kirsten Wesenhagen, Betty Tijms, Charlotte Teunissen, Pieter Jelle Visser, Linus Jönsson
medRxiv 2023.01.24.23284478; doi: https://doi.org/10.1101/2023.01.24.23284478
Subject Area
Subject Areas
- Addiction Medicine (317)
- Allergy and Immunology (621)
- Anesthesia (162)
- Cardiovascular Medicine (2317)
- Dermatology (205)
- Emergency Medicine (373)
- Epidemiology (11653)
- Forensic Medicine (10)
- Gastroenterology (687)
- Genetic and Genomic Medicine (3655)
- Geriatric Medicine (344)
- Health Economics (625)
- Health Informatics (2340)
- Health Policy (922)
- Hematology (337)
- HIV/AIDS (765)
- Medical Education (362)
- Medical Ethics (102)
- Nephrology (394)
- Neurology (3406)
- Nursing (193)
- Nutrition (512)
- Oncology (1787)
- Ophthalmology (529)
- Orthopedics (212)
- Otolaryngology (284)
- Pain Medicine (227)
- Palliative Medicine (66)
- Pathology (442)
- Pediatrics (1014)
- Primary Care Research (411)
- Public and Global Health (6046)
- Radiology and Imaging (1243)
- Respiratory Medicine (816)
- Rheumatology (373)
- Sports Medicine (319)
- Surgery (391)
- Toxicology (50)
- Transplantation (171)
- Urology (144)